Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study yesterday.
Presenting the findings at the European Society of Cardiology’s annual meeting in London, they said the study showed for the first time that blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the following three decades.
“This is good for patients first and foremost, but it is also important information for [manufacturers of] cholesterol lowering drugs, anti-inflammatory drugs and lipoprotein(a)-lowering drugs — the implications for therapy are broad,” said Paul Ridker of Brigham and Women’s Hospital in Boston, the study leader.
Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data ... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of five or 10 year risk.”
The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low-density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.
They also had tests for high-sensitivity C-reactive protein (hsCRP) — a marker of blood vessel inflammation — and lipoprotein(a), a genetically determined type of fat.
Compared with risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the following 30 years were 36 percent higher in women with the highest levels of LDL-C, 70 percent higher in women with the highest levels of hsCRP and 33 percent higher in those with the highest levels of lipoprotein(a).
Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the following three decades, said a report of the study in The New England Journal of Medicine that was published to coincide with the presentation at the meeting.
“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said. “The therapies we might use in response to an elevation in each biomarker are markedly different and physicians can now specifically target the individual person’s biologic problem.”
While drugs that lower LDL-C and hsCRP are widely available — including statins, and pills for high blood pressure and heart failure — drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis, Amgen, Eli Lilly and London-based Silence Therapeutics.
Lifestyle changes such as exercising and quitting smoking can also be helpful.
Most of the women in the study were white Americans, but the findings would likely “have even greater impact among black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.
“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”
Kehinde Sanni spends his days smoothing out dents and repainting scratched bumpers in a modest autobody shop in Lagos. He has never left Nigeria, yet he speaks glowingly of Burkina Faso military leader Ibrahim Traore. “Nigeria needs someone like Ibrahim Traore of Burkina Faso. He is doing well for his country,” Sanni said. His admiration is shaped by a steady stream of viral videos, memes and social media posts — many misleading or outright false — portraying Traore as a fearless reformer who defied Western powers and reclaimed his country’s dignity. The Burkinabe strongman swept into power following a coup in September 2022
‘FRAGMENTING’: British politics have for a long time been dominated by the Labor Party and the Tories, but polls suggest that Reform now poses a significant challenge Hard-right upstarts Reform UK snatched a parliamentary seat from British Prime Minister Keir Starmer’s Labor Party yesterday in local elections that dealt a blow to the UK’s two establishment parties. Reform, led by anti-immigrant firebrand Nigel Farage, won the by-election in Runcorn and Helsby in northwest England by just six votes, as it picked up gains in other localities, including one mayoralty. The group’s strong showing continues momentum it built up at last year’s general election and appears to confirm a trend that the UK is entering an era of multi-party politics. “For the movement, for the party it’s a very, very big
A new online voting system aimed at boosting turnout among the Philippines’ millions of overseas workers ahead of Monday’s mid-term elections has been marked by confusion and fears of disenfranchisement. Thousands of overseas Filipino workers have already cast their ballots in the race dominated by a bitter feud between President Ferdinand Marcos Jr and his impeached vice president, Sara Duterte. While official turnout figures are not yet publicly available, data from the Philippine Commission on Elections (COMELEC) showed that at least 134,000 of the 1.22 million registered overseas voters have signed up for the new online system, which opened on April 13. However,
ENTERTAINMENT: Rio officials have a history of organizing massive concerts on Copacabana Beach, with Madonna’s show drawing about 1.6 million fans last year Lady Gaga on Saturday night gave a free concert in front of 2 million fans who poured onto Copacabana Beach in Rio de Janeiro for the biggest show of her career. “Tonight, we’re making history... Thank you for making history with me,” Lady Gaga told a screaming crowd. The Mother Monster, as she is known, started the show at about 10:10pm local time with her 2011 song Bloody Mary. Cries of joy rose from the tightly packed fans who sang and danced shoulder-to-shoulder on the vast stretch of sand. Concert organizers said 2.1 million people attended the show. Lady Gaga
RSS